Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
55 µg/mL
Hemolytic
Cytotoxic
0% Hemolysis | 55 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Antimicrobial Cationic Peptides | Patent US 6906035 B2 | 2005